![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 18, 13789-13792, May 5, 2000
From the Departments of We have previously reported that
14,15-epoxyeicosatrienoic acid (14,15-EET) is a potent mitogen for the
renal epithelial cell line, LLCPKcl4. This mitogenic effect is
dependent upon activation of a protein-tyrosine kinase cascade that
results in activation of mitogen-activated protein kinase and
phosphatidylinositol 3-kinase. Because of suggestive evidence that
14,15-EET also activated Src in these cells, we stably transfected
LLCPKcl4 with an expression construct of the C-terminal Src kinase
(CSK), which inhibits Src family kinase activity. In vitro
Src kinase activity assays confirmed that in empty vector-transfected
cells (Vector cells), 14,15-EET increased Src kinase activity, while in
clones overexpressing CSK mRNA and immunoreactive protein (CSK
cells), 14,15-EET-induced activation of Src was almost completely
blocked (94% inhibition). Of interest, epidermal growth factor (EGF)
and fetal bovine serum (FBS) also increased Src activity in Vector
cells, but not in CSK cells, further confirming the ability of CSK
overexpression to prevent Src activation. CSK cells failed to increase
[3H]thymidine incorporation in response to exogenous
14,15-EET. In contrast, both EGF and FBS significantly increased
[3H]thymidine incorporation in CSK cells.
Immunoprecipitation with anti-phosphotyrosine antibodies and
immunoblotting with an antibody against extracellular signal-regulated
kinase (ERK) indicated that in CSK cells, 14,15-EET failed to activate
ERK1 and ERK2; however, EGF- and FBS-induced activation of ERKs was not
different from that seen in Vector cells. In Vector cells, the
14,15-EET-stimulated tyrosine phosphorylation of ERKs was blocked by
pretreatment with 1 µM PP2, a selective inhibitor of Src
kinases. The present study demonstrates that 14,15-EET exerts its
mitogenic effects predominantly through a Src kinase-mediated pathway,
which is the most upstream signaling step determined to date in the
14,15-EET-activated tyrosine kinase cascade in renal epithelial cells.
Overexpression of C-terminal Src Kinase Blocks
14,15-Epoxyeicosatrienoic Acid-induced Tyrosine Phosphorylation and
Mitogenesis*
,
§, and
¶
Medicine and
§ Biochemistry, Vanderbilt University,
Nashville, Tennessee 37232
*
This work was supported by National Institutes of Health
Grant DK38226.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J.-K. Chen, J. Chen, J. D. Imig, S. Wei, D. L. Hachey, J. S. Guthi, J. R. Falck, J. H. Capdevila, and R. C. Harris Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors J. Biol. Chem., September 5, 2008; 283(36): 24514 - 24524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R. C. Venema, and G. N. Rao An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis Blood, June 15, 2008; 111(12): 5581 - 5591. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, Y. Wei, J. R. Falck, K. R. Atcha, and W.-H. Wang Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1441 - F1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, L. Lin, J.-X. Chen, C. R. Lee, J. M. Seubert, Y. Wang, H. Wang, Z.-R. Chao, D.-D. Tao, J.-P. Gong, et al. Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-{alpha} via MAPK and PI3K/Akt signaling pathways Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H142 - H151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J.-K. Chen, J. R. Falck, S. Anjaiah, J. H. Capdevila, and R. C. Harris Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate Metabolite Mol. Cell. Biol., April 15, 2007; 27(8): 3023 - 3034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J.-K. Chen, E. G. Neilson, and R. C. Harris Role of EGF Receptor Activation in Angiotensin II-Induced Renal Epithelial Cell Hypertrophy J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1615 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, H. Cao, and G. N. Rao Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis J. Biol. Chem., January 13, 2006; 281(2): 905 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, H. Cao, and G. N. Rao 15(S)-Hydroxyeicosatetraenoic Acid Induces Angiogenesis via Activation of PI3K-Akt-mTOR-S6K1 Signaling Cancer Res., August 15, 2005; 65(16): 7283 - 7291. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Potente, B. Fisslthaler, R. Busse, and I. Fleming 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1 J. Biol. Chem., August 8, 2003; 278(32): 29619 - 29625. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Cottrell, R. Lin, B. J. Warn-Cramer, A. F. Lau, and J. M. Burt Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication Am J Physiol Cell Physiol, February 1, 2003; 284(2): C511 - C520. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zhang and D. R. Harder Cerebral Capillary Endothelial Cell Mitogenesis and Morphogenesis Induced by Astrocytic Epoxyeicosatrienoic Acid Stroke, December 1, 2002; 33(12): 2957 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Alkayed, T. Goyagi, H.-D. Joh, J. Klaus, D. R. Harder, R. J. Traystman, and P. D. Hurn Neuroprotection and P450 2C11 Upregulation After Experimental Transient Ischemic Attack Stroke, June 1, 2002; 33(6): 1677 - 1684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, X. Sui, J. A. Bradbury, D. C. Zeldin, M. S. Conte, and J. K. Liao Inhibition of Vascular Smooth Muscle Cell Migration by Cytochrome P450 Epoxygenase-Derived Eicosanoids Circ. Res., May 17, 2002; 90(9): 1020 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Cytochrome P450 and Vascular Homeostasis Circ. Res., October 26, 2001; 89(9): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Capdevila, and R. C. Harris Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis Mol. Cell. Biol., September 15, 2001; 21(18): 6322 - 6331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Robey, O. S. Ruiz, J. Baniqued, D. Mahmud, D. J. D. Espiritu, A. A. Bernardo, and J. A. L. Arruda SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO3 cotransport activity in renal epithelial cells Am J Physiol Renal Physiol, May 1, 2001; 280(5): F844 - F850. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Zeldin Epoxygenase Pathways of Arachidonic Acid Metabolism J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |